A novel Ras antagonist regulates both oncogenic Ras and the tumor suppressor p53 in colon cancer cells.

بواسطة Halaschek-Wiener, J., Wacheck, V., Schlagbauer-Wadl, H., Wolff, K., Kloog, Y., Jansen, B.
منشور في 2000

Bcl-x(L) antisense oligonucleotides radiosensitise colon cancer cells

بواسطة Wacheck, V, Selzer, E, Günsberg, P, Lucas, T, Meyer, H, Thallinger, C, Monia, B P, Jansen, B
منشور في 2003

FDG uptake is a surrogate marker for defining the optimal biological dose of the mTOR inhibitor everolimus in vivo

بواسطة Cejka, D, Kuntner, C, Preusser, M, Fritzer-Szekeres, M, Fueger, B J, Strommer, S, Werzowa, J, Fuereder, T, Wanek, T, Zsebedics, M, Mueller, M, Langer, O, Wacheck, V
منشور في 2009

Dose study of the multikinase inhibitor, LY2457546, in patients with relapsed acute myeloid leukemia to assess safety, pharmacokinetics, and pharmacodynamics

بواسطة Wacheck V, Lahn M, Dickinson G, Füreder W, Meyer R, Herndlhofer S, Füreder T, Dorfner G, Pillay S, André V, Burkholder TP, Akunda JK, Flye-Blakemore L, Van Bockstaele D, Schlenk RF, Sperr W, Valent P
منشور في 2011-05-01